European Patent Office

T 0434/23 (Meningococcal factor H binding protein/GLAXOSMITHKLINE) of 05.08.2025

European Case Law Identifier
ECLI:EP:BA:2025:T043423.20250805
Date of decision
5 August 2025
Case number
T 0434/23
Online on
13 January 2026
Petition for review of
-
Application number
10713516.2
IPC class
A61K 39/095
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Adjuvanting meningococcal factor H binding protein
Applicant name
GlaxoSmithKline Biologicals SA
Opponent name
Sanofi Pasteur
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 100(a)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(3)Rules of procedure of the Boards of Appeal 2020 Art 012(5)
Keywords
Inventive step - (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed.